Abstract
A study of the effect of the hypotensive drug Dopegyt on the effective renal plasma flow, the peripheral renal resistance and the isotope nephrography with131I-hippuran was carried out in 12 patients with renal hypertension and compensated renal function. The authors established that the hypotensive action of Dopegyt was not associated with significant changes in the indices studied. Based on these data, it is suggested that arterial hypertension in renal diseases should be treated with Dopegyt.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cannon, P. J., Whitlock, R. T., Morris, R. C., Angers, M., Laragh, J. H.: Effect of alphamethyl-dopa in severe and malignant hypertension.J. Amer. med. Ass. 179, 673 (1962).
Franke, H.: Das Isotopennephrogramm bei alpha-methyl-Dopa behandelten Hypertonikern. Symposium Ther. der Bluthochdruckes. Freiburg, 1963.
Gotze, H.: Verhalten der Nierenfunktion unter alpha-methyl-Dopa bei verschiedenen Hypertonieformen. In: Hochdruckforschung. Stuttgart, 1965.
Glezer, G. A., Puskar, Ju. T., Spivak, G. L., Moskalenko, N. P., Afanaseva, L. S., Soboleva, V. A.: The influence of alpha-methyldopa (Dopegyt) on some circulation indices.Sov. Med. 2, 21 (1969).
Juchems, R., Ruhl, E., Deibert, K.: Experimentelle Untersuchungen zur Wirkung des Alpha-Methyl-Dopa auf die Kreatininclearance bei Hypertonikern.Med. Welt 11, 2860 (1965).
Luke, R. G., Kennedy, A. C.: Methyldopa in treatment of hypertension due to chronic renal disease.Brit. med. J. 1, 27 (1964).
Mitrov, G.: Possibilities of the isotope clearance-methods. In: Proceedings of the IIIrd Congress of the Bulgarian Roentgenologists and Radiologists, Varna, 25–28 September, 1970.
Onesti, G., Brest, A. N., Novack, P., Kasparian, H., Moyer, J. H.: Pharmacodynamic effects of alpha-methyl-dopa in hypertensive subjects.Amer. Heart J., 67, 32 (1964).
Paquet, K. J., Blittesdorf, F.: Klinische Ergebnisse der Therapie mit Alpha-Methyl-Dopa, insbesondere seiner Wirkung auf den Serumkaliumgehalt und die Nierenfunktion.Med. Welt I, 794 (1967).
Radó, J., Bános, C., Takó, J.: Die Wirkung von Alpha-Methyl-Dopa (Dopegyt) und anderen Antihypertonika (Guanethidin, Bethanidin) auf das Isotopennephrogramm.Ther. hung. 2, 79 (1969).
Sannerstedt, R., Bojs, G., Varnauskas, E., Werkő, L.: Alpha-methyldopa in arterial hypertension. Clinical, renal and hemodynamic studies.Acta. med. Scand. 174, 53 (1963).
Sarre, H., Oechslen, D.: Therapie des renalen Hochdrucks mit Alpha-Methyl-Dopa (Presinol) und Cyclazerin (Leron).Med. Klin. 62, 561 (1967).
Szivkov, I. I., Szokolov, B. P., Kukesz, V. G., Feldman, Sz. F., Csevisev, N. Sz.: Clinical apparaisal of alpha-methyldopa efficacy in hypertensive disease.Szov. Med. 2, 13 (1969).
Vorburger, C., Lüthi, H., Reubi, F.: Erfahrungen mit 1-Alpha-Methyl-Dopa (Aldomet) in der Hypertonie.Schweiz. med. Wschr. 95, 238 (1965).
Weil, M. H., Barbour, B. H., Chesne, R. B.: Alpha-methyl-dopa for the treatment of hypertension. Clinical and pharmacodynamic studies.Circulation 28, 165 (1963).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Majdrakov, G., Mitrov, G., Mushmov, D. et al. Effect ofα-methyldopa on renal plasma flow in patients with renal hypertension. International Urology and Nephrology 3, 289–293 (1971). https://doi.org/10.1007/BF02081768
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02081768